NCT06066255 2024-02-20
CASPER
Institut Paoli-Calmettes
Phase 2 Unknown
Clinical Trials
14 trialsNCT01374841 2023-06-28
Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors
European Institute of Oncology
Phase 2 Unknown
NCT04809181 2023-02-21
Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients
First Affiliated Hospital of Zhejiang University
Phase 2 Unknown
NCT05413356 2022-10-19
Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome
First Affiliated Hospital of Zhejiang University
Phase 2 Unknown
NCT05084027 2021-10-27
Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT
First Affiliated Hospital of Zhejiang University
Phase 2 Unknown
NCT03146468 2021-09-23
NIVALLO
Melbourne Health
Phase 2 Unknown
NCT01332006 2018-11-13
Intra-bone Cord Blood Transplantation
Università degli Studi di Brescia
Phase 2 Unknown
NCT03320915 2017-10-25
Efficacy and Safety of High Dose Vitamin D Supplementation in Patients Undergoing HSCT
Seoul National University Hospital
Phase 2 Unknown
NCT01757145 2015-06-19
Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood Transplantation
Rabin Medical Center
Phase 2 Unknown
NCT02385955 2015-03-11
Phase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult Patients
Seoul National University Hospital
Phase 2 Unknown
NCT01788605 2014-12-08
Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation
The Catholic University of Korea
Phase 2 Unknown
NCT00959231 2013-08-26
Donor Umbilical Cord Blood Transplant After Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00750126 2011-01-19
RICE
University Hospital, Clermont-Ferrand
Phase 2 Unknown
NCT00129155 2007-10-04
MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies
Hospices Civils de Lyon
Phase 2 Unknown